China -  Chinese law firm

Vol.3, No.08

CHINA HEALTH SCIENCES NEWSLETTER

Vol. 3 , No.8 - March 27, 2002

TOPICS THIS ISSUE:

  • First Asian Biotech Summit to be Held in Beijing
  • World Bank and Britain To Join China In Fight Against TB
  • AIDS Patients In Guangzhou Increased 80%
  • Deputy Urges More Action Against AIDS
  • European Pharmaceutical Companies To Enter China
  • Retail Price Index Of Medicine In 36 Chinese Cities
  • German Pharmaceutical Company To Open Factory in Shanghai
  • First Ovary Transplant Successful in China
  • List of China GMP Facilities (Continued)

First Asian Biotech Summit to be Held in Beijing

The first Asian Biotech Summit, aiming to promote the commercial application of the latest biological technology, will be held in Beijing in June this year.

Co-organized by the Pacific Rim Forum and the China Council for the Promotion of International Trade, about 500 participants from the region's industries, institutions and government bodies will take part in the summit.

(Source:People's Daily)

World Bank and Britain To Join China In Fight Against TB

Two million Chinese people could be saved from tuberculosis and more will be prevented from infection in the next seven years thanks to a TB control program jointly launched by China, Britain and the World Bank.

The program, mainly financed by a US$ 104 million loan from the World Bank, will offer free diagnosis and treatment of tuberculosis in 16 of China's 31 provinces to over 680 million people.

(Source: Xinhua News Agency)

AIDS Patients In Guangzhou Increased 80%

The Guangzhou-based Nanfang Daily reported that the number of AIDS patients in Guangzhou is increasing at an average of 80.64% a year. Last year alone, 212 HIV positive cases were reported in the southern Chinese metropolis, or a 128% increase. The municipal government has stated that it will take active measures to check the spread of the fatal disease.

(Source: Hong Kong Editor)

Deputy Urges More Action Against AIDS

The first AIDS-prevention proposal ever presented by a National People's Congress deputy was put forward at the Fifth Session of the Ninth National People's Congress in Beijing this March. He said that reading a recent newspaper article on an AIDS patient moved him to put forward the proposal.

(Source: Xinhua News Agency)

European Pharmaceutical Companies To Enter China

A meeting promoting the health science and technology industry in China was recently held in Frankfurt.

A survey at the meeting showed that there are increasing numbers of European pharmaceutical companies that consider China a strategic base for long-term development. Representatives from more than 70 pharmaceutical companies from Germany, Britain, France, Switzerland, the Netherlands and the United States were present at the meeting.

(Source: Asia Pulse)

 

Profitable China GMP Facilities for Sale
Send email to mail@chinalaw.cc for further information.

 

Retail Price Index Of Medicine In 36 Chinese Cities

The following is a table showing the retail price index of medicine in 36 cities for the month of December 2001. December 2000 is 100.

City

Price Index

Average of 36 Cities

97.2

Beijing

100.3

Tianjin

97.7

Shijiazhuang

95.1

Taiyuan

99.1

Hohhot

97.6

Shenyang

92.4

Dalian

101.4

Changchun

97.3

Harbin

92.8

Shanghai

96.7

Nanjing

104.2

Hangzhou

92.9

Ningbo

100.4

Hefei

98.3

Fuzhou

93.7

Xiamen

96.6

Nanchang

105.5

Jinan

98.3

Qingdao

94.9

Zhengzhou

99.7

Wuhan

90.7

Changsha

99.0

Guangzhou

94.6

Shenzhen

98.8

Nanning

97.9

Haikou

90.8

Chongqing

100.0

Chengdu

101.8

Guiyang

93.9

Kunming

95.6

Lhasa

106.7

Xi'an

91.3

Lanzhou

96.7

Xining

94.0

Yinchuan

96.1

Urumqi

98.9

(Source: National Bureau of Statistics)

German Pharmaceutical Company To Open Factory in Shanghai

The world's leading medicine manufacturer, German-based Boehringer Ingelheim, plans to set up a Sino-German joint venture, Boehringer Ingelheim Shanghai Pharmaceuticals Co Ltd., in Pudong, Shanghai.

The new factory will be a core base for Boehringer Ingelheim to supply medicines and chemical re-agents to China. It is hoped that the joint venture will help the German company in its expansion efforts in the Chinese mainland and strengthen its production network in Japan, Indonesia, South Korea and Taiwan.

(Source: Asia Pulse)

First Ovary Transplant Successful in China

The first ovary transplant operation was conducted in east China's Zhejiang Province and gave the patient a second chance at a normal life.

The China Daily reported that Tang Fangfang, 34, the recipient of the ovary, was discharged from the hospital after recovery on Monday. "We have never performed such an operation before, and we are glad we did it," said Zheng Wei a professor at the Second Affiliated Hospital at Zhejiang Medical Science University, where the operation was conducted on March 5.

He added that such operations had only been performed on animals before. Doctors said she needed an ovary transplant and her sister was fortunately a match.

"This is a very unusual case because such matches usually only exist among twins," Zheng said. He added "the newly planted ovary is working properly in Fangfang's body now. "

Experts said that this operation is comparable to the "test-tube baby" in regards to reproductive surgery. It is hoped that more operations will be performed on women who are unable to have children because of cancer treatment.

(Source: Xinhua News Agency)

 

China Pharma Distribution Company for Sale
Send email to mail@chinalaw.cc for further information.

 

List of China GMP Facilities (Continued)

Name of Enterprise

Certified Scope

901. Wuxi 7th Pharmaceutical Factory

High dose Injection

902.Shenzhen Zhonglian Pharmaceutical Factory

Chemical bulk

903. SmithKlein Beecham (Tianjin) Co., Ltd.

Tablet, Eye-drops, Ointment

904. Beijing Shuanglu Pharmaceutical Co., Ltd.

Rhg-CFS

905. Dongguan Wancheng Pharmaceutical Co., Ltd.

Tablet, Capsule, Granule

906. Livzon Group Suzhou Xinbao Pharmaceutical Factory

Freeze-dried powder-injection, Low dose injection

907. Hangzhou Huqingyutang Pharmaceutical Co., Ltd.

Tablet, Granule, Capsule

908. Anhui Tiankang Pharmaceutical Co., Ltd.

Tablet, Capsule, Granule

909. Hunan Zhengqing Pharmaceutical Group Co., Ltd. by Shares

Tablet

910. Hunan Zhengqing Pharmaceutical Group Co., Ltd. by Shares

Capsule

911. Sichuan Meidakang Pharmaceutical Co., Ltd.

Tablet, Capsule, Granule, Oral liquid

912. Beijing Mengdi Pharmaceutical Co., Ltd.

Tablet

913. Hangzhou Aida Pharmaceutical Co., Ltd.

High dose injection

914. Shantou Yalian Pharmaceutical Co., Ltd.

High dose injection

915. Beijing Sihuan Bio-engineering Products Factory

Recombinant human hematopoiesis

916. Shandong Shengli Pharmaceutical Co., Ltd.

Oral liquid, Tablet, Granule

917. Tianjin Pharmaceutical Jiaozuo Co., Ltd.

Low dose injection, Freeze-dried powder-injection

918. Jilin Kangwei Pharmaceutical Group

Capsule, Tablet, Granule

919. Nanjing Changao Pharmaceutical Co., Ltd

Tablet, Capsule

920.Shenzhen Kangtai Bio-Products Co., Ltd.

Hepatitis B Vaccine

921. Shenzhen Yuanzhen Pharmaceutical Co., Ltd.

Bulk, Ointment, Tablet, Capsule

922. Shenzhen Yuanzhen Pharmaceutical Co., Ltd.

Granule

923. Jilin Aodong Zhuhai Pharmaceutical Co., Ltd.

Capsule, Oral liquid

924. Anhui Fuyang Pharmaceutical Factory

High dose injection

925. Guangzhou Jingxiutang (Pharmaceutical) Co., Ltd by Shares

Tincture

926. Shanghai Alpha Bio-tech Co., Ltd.

Exosomatic diagnostic agent

927. Beijing Leipo Pharmaceutical Factory

Tablet, Capsule

928. Guanzhou Nanxin Pharmaceutical Co., Ltd.

Granule, Capsule, Suspension

929. Guanzhou Nanxin Pharmaceutical Co., Ltd.

Tablet

930. Guilin Sanjin Pharmaceutical Co., Ltd.

Tablet, Capsule, Powder

931. Shanghai Ajinomoto Co. Inc.

Bulk (Amino acid)

932. Yunnan Wenshan Teanna Pharmaceutical Co., Ltd.

Tablet, Capsule, Granule

933. Qingyuan Huaneng Pharmaceutical Co., Ltd.

Tablet, Capsule, Granule

934. Shanxi Tongling Pharmaceutical Co., Ltd.

Powder-injection, Bulk

935. Guangdong Shiqi Pharmaceutical Factory

Powder-injection

936. Suzhou Zhongkai Bio-pharma Co., Ltd.

RhG-CFS

937. Chongqing Huabang Pharma Co., Ltd.

Tablet, Capsule, Ointment, Low dose injection, Bulk

938. Shanghai Changzheng Fumin Pharma Co., Ltd.

High dose injection

939. Shanghai Naikeming Pharma Co., Ltd.

High dose injection, Low dose injection, Tablet

940. Taifeng (Jiangxi) Pharmaceutical Co., Ltd.

High dose injection

941. Jiangsu Shengbaoluo Pharmaceutical Co., Ltd.

Tincture, Ointment

942. Hainan Linheng Pharmaceutical Factory

Tablet, Capsule

943. Shannxi Hanjiang Pharmaceutical Co., Ltd. by Shares

Bulk

944. Zhengda Qingchunbao Pharma Co., Ltd.

High dose injection, Low dose injection

945. Tianjin Huajin Pharmaceutical Factory

Tablet, Capsule

946. Guangzhou Guanghua Pharmaceutical Co., Ltd by Shares.

Capsule

947. Guangdong Xinbeijiang Pharmaceutical Co., Ltd.

Capsule

948. Shanghai Hefeng Pharmaceutical Co., Ltd.

Low dose injection

949. Sanmenxia Jinqu Co., Ltd.

Powder injection, Tablet, Capsule

950. Shenyang Sansheng Pharmaceutical Co., Ltd. by Shares

Recombinant human hematopoiesis

 


Lehman Lee & Xu

China Lawyers, Notaries, Patent, Copyright and Trademark Agents

http://www.chinalaw.cc/

Beijing Office

Shanghai Office

6th floor, Dongwai Diplomatic Office Building
23 Dongzhimenwai Dajie
Beijing 100600 China
Tel.: (86)(10) 8532-1919
Fax: (86)(10) 8532-1999
Email: mail@chinalaw.cc

Suite 5107, Plaza 66
No. 1266, West Nanjing Road
Shanghai 200040 China

Tel: (86)(21) 6375-8240

Fax:(86)(21) 6375-8705
Email: shanghai@chinalaw.cc

Shenyang

Hong Kong

Guangzhou

Chengdu

To unsubscribe from this newsletter send an email to
unsub-hs@lehmanlaw.comPlease include the email address to which the newsletter is being sent (not a forwarded address) in the body of the email.

The China Health Sciences Newsletter is intended to be used for news purposes only. It should not be taken as comprehensive legal advice, and Lehman, Lee & Xu will not be held responsible for any such reliance on its contents.

RSS Feeds